United States · 
Who invested in Avenue Biosciences?
Avenue Biosciences's investors include Inventure and Voima Ventures.
United States · Seed startup
Who invested in Avenue Biosciences
Funding summaryUpdated 26 Oct 2026
$7.4Mraised across 1 round since 2026, from 1 source
- Latest round
- Seed, $7.4MJan 2026
- Investors
- 2
The rounds
- Jan 2026
Founders and team
From Avenue Biosciences's own website: 1 founder, 3 on the team.
Tero-Pekka AlastaloCOO, co-founder
- Katja RostiCTO
- Anton KlåvusData Science Director
- Juulia SimonenData Science Director
AdvisersSofia Lund
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Avenue Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Avenue Biosciences
How much has Avenue Biosciences raised?
Avenue Biosciences has raised $7.4M across 1 round since 2026.
When did Avenue Biosciences last raise?
Avenue Biosciences's most recent round was a Seed of $7.4M in Jan 2026.
What was Avenue Biosciences's biggest round?
Its most recent round, $7.4M in Jan 2026, is also its largest on record.
Who backed Avenue Biosciences first?
Avenue Biosciences's first round on record, in Jan 2026, was backed by Inventure and Voima Ventures.
What stage is Avenue Biosciences at?
Avenue Biosciences's latest named round is a Seed, in Jan 2026.
Where is Avenue Biosciences based?
Avenue Biosciences is based in the United States.
Companies like Avenue Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.